Subspecialties: Page 130

Alpha Tau cleared to launch Alpha DaRT trial

By AuntMinnie.com staff writers

Israeli radiation therapy technology developer Alpha Tau Medical has received clearance in Canada to launch a trial of its Alpha DaRT treatment for liver cancer.

March 2, 2023

AI can catch missed diagnoses on chest radiographs

By Erik L. Ridley

VIENNA - An artificial intelligence (AI)-based software application can identify missed clinically significant findings in chest radiographs, according to research presented on March 3 at ECR 2023.

March 2, 2023

ECR: SMI with elastography shows promise, still lower than TI-RADS

By Amerigo Allegretto

Superb microvascular imaging (SMI) with elastosonography may not be as valuable as standard TI-RADS, but it does hold some potential, according to findings presented March 1 at ECR 2023.

March 2, 2023

FAPI-PET shows promise in patients with RA

By Will Morton

FAPI-PET can visualize changes in the joints of patients with rheumatoid arthritis (RA) and appears promising as a tool for monitoring patients undergoing treatment, according to a study published February 28 in Radiology.

March 1, 2023

ECR: AI can help radiologists detect more fractures

By Erik L. Ridley

VIENNA - When it comes to detecting fractures on radiographs, radiologists and artificial intelligence (AI) software are better together, according to research presented March 2 at ECR 2023.

March 1, 2023

Researchers sing PCCT's praises

By Kate Madden Yee

VIENNA - ECR 2023 kicked off with high enthusiasm for photon-counting CT (PCCT) as researchers shared data about the technology's benefits.

March 1, 2023

Men report improved symptoms after enlarged prostate procedure

By Will Morton

Minimally invasive prostate artery embolization is an effective long-term treatment for men with enlarged prostate glands, according to researchers at a February 28 news conference held by the Society of Interventional Radiology.

March 1, 2023

Enrollment complete in Ascelia's new contrast agent trial

By AuntMinnie.com staff writers

Ascelia Pharma said it reached a milestone with enrollment now complete in its phase III study for Orviglance, a new MRI contrast agent for patients with kidney impairment.

February 28, 2023

Paid sick leave tied to higher cancer screening rates

By Amerigo Allegretto

Mandatory paid sick leave is tied to more cancer screening, suggest findings published March 1 in the New England Journal of Medicine.

February 28, 2023

Ultrasound ablation improves motor function in Parkinson's disease patients

By Amerigo Allegretto

Ultrasound ablation potentially improves motor function and reduces dyskinesia in patients with Parkinson's disease, according to research published February 23 in the New England Journal of Medicine.

February 28, 2023

Fracture risk tool validated in men with prostate cancer

By Will Morton

Researchers in Canada have for the first time validated the Fracture Risk Assessment Tool (FRAX) in men with prostate cancer, according to a study published February 20 in the Journal of Bone and Mineral Research

February 28, 2023

Medimaps reveals AI results for osteoporosis diagnosis and monitoring at ECR

By AuntMinnie.com staff writers

Swiss imaging software developer Medimaps Group has presented results at ECR 2023 that show its new spine segmentation (SpS) artificial intelligence (AI) algorithm may be a reliable, time-efficient tool to enhance patient monitoring and osteoporosis diagnosis.

February 28, 2023

Previous Page

Page 130 of 1582

Next Page